Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)		Total	Underwriters in Private Placement	Initial Public Offering	Founders	Founders Private Placement	Common Stock	Common Stock Underwriters in Private Placement	Common Stock Initial Public Offering	Common Stock Founders	Common Stock Founders Private Placement	Additional Paid-in Capital	Additional Paid-in Capital Underwriters in Private Placement	Additional Paid-in Capital Initial Public Offering	Additional Paid-in Capital Founders	Additional Paid-in Capital Founders Private Placement	Accumulated Deficit
Balance at Feb. 02, 2020
Balance, Shares at Feb. 02, 2020
Sale of common stock			$ 2,434,790	$ 187,267,093	$ 25,000	$ 6,500,000		$ 24	$ 2,000	$ 574	$ 65		$ 2,434,766	$ 187,265,093	$ 24,426	$ 6,499,935
Sale of common stock, Shares								243,479	20,000,000	5,735,000	650,000
Issuance of common stock to Insiders for no consideration							$ 2					(2)
Issuance of Insider shares for no consideration, Shares		15,000					15,000
Forfeiture of common stock sold to Founder due to over-allotment not being exercised	[1]						$ (75)					75
Forfeiture of common stock sold to Founder due to over-allotment not being exercised, shares	[1]						(750,000)
Shares subject to redemption		$ (190,770,164)					$ (1,889)					(190,768,275)
Shares subject to redemption, Shares							(18,888,135)
Net loss		(456,716)															(456,716)
Balance at Sep. 30, 2020		$ 5,000,003					$ 701					5,456,018					(456,716)
Balance, Shares at Sep. 30, 2020		7,005,344					7,005,344
Balance at Jun. 30, 2020		$ 5,000,008					$ 698					5,156,706					(157,396)
Balance, Shares at Jun. 30, 2020							6,977,194
Reduction to offering costs		15,000										15,000
Shares subject to redemption		284,315					$ 3					284,312
Shares subject to redemption, Shares							28,150
Net loss		(299,320)															(299,320)
Balance at Sep. 30, 2020		$ 5,000,003					$ 701					$ 5,456,018					$ (456,716)
Balance, Shares at Sep. 30, 2020		7,005,344					7,005,344

[1] 750,000 Founder Shares were forfeited because the over-allotment option was not exercised by the Underwriters (see Note 4).